The Association of the British Pharmaceutical Industry (ABPI)

Only 4 days left to submit your nomination for the EDI Heroes Award! Looking for inspiration or last-minute tips for your submission? Get inspired by our judges—today's tip is from Andrew Croydon, Director, Education and Examination Policy and Partnerships, The Association of the British Pharmaceutical Industry (ABPI) Nominate here: https://lnkd.in/esNMAZZb In partnership with Skills and Education Group and University Vocational Awards Council (UVAC). #Apprentice #EDIHeroesAwards2025 #EDIAwards2025 #HigherEducation #TechnicalEducation#VocationalEducation #FutherEducation

📣 Patients, the NHS and the life sciences sector are set to benefit from a new clinical trials framework being laid in parliament today. New clinical trials legislation has been laid in UK Parliament today, 12 December, that will address the research sector's need for a more efficient, streamlined and adaptable regulatory framework for clinical trials. The new legislation will make the UK a more attractive place for innovators to conduct important research and will help to get potentially life-changing new treatments to patients and the NHS as quickly as possible. Dr June Raine, our Chief Executive said:  “A major milestone for clinical trials regulations has been achieved today. “After extensive public consultation and expert input, we’re introducing regulations that eliminate unnecessary duplication and accelerate approvals. “These reforms protect the safe development of pioneering new treatments for the benefit of patients and the NHS, setting the UK as one of the best places in the world to conduct research for patients, researchers and innovators” To read the full release, visit ➡️ https://bit.ly/3ZTxuUX

Three key reports have recently been published that feature the work of Health Innovation Manchester in advancing healthcare through innovation: 1. The King's Fund: NHS and Life Sciences Partnerships Report: This report, commissioned by the The Association of the British Pharmaceutical Industry (ABPI) and conducted by The King’s Fund, highlights how collaborative projects between the NHS and the life sciences sector can improve patient care and drive innovation. A notable example included in the report is the involvement of Health Innovation Manchester in the STARRS-GM project, supporting improved asthma care in Greater Manchester by using data analytics and guided consultation software. This collaboration with AstraZeneca and LungHealth Ltd has shown promising results in managing asthma for high-risk patients. Find out more: https://lnkd.in/eFuPJzDw 2. Health Innovation Network 2023-24 Impact Report: As one of 15 Health Innovation Networks across the country, Health Innovation Manchester has contributed to the national impact of various programmes and initiatives, supporting the care of over 1.23 million patients. Economically, the networks leveraged £467 million to support innovators, creating and safeguarding over 1,300 jobs. Key health improvements include the Innovation for Healthcare Inequalities Programme (InHIP), which engaged 34,000 people from underserved populations, and a lipid management programme that prevented over 9,000 serious cardiovascular events. Safety interventions in maternity and neonatal care have saved nearly 1,200 babies' lives. Find out more: https://lnkd.in/eNcEYQMd 3. Health Innovation Network Innovation for Healthcare Inequalities Programme (InHIP) Report: The InHIP report focuses on addressing healthcare inequalities across England. Health Innovation Manchester played a crucial role in several initiatives, including paediatric asthma and smoking cessation. By identifying and treating asthma in children and supporting families to quit smoking, outcomes have been significantly improved in deprived areas. Projects tailored to community needs, such as providing FeNO testing and smoking cessation support, have demonstrated the power of local engagement and working with the community. Find out more: https://lnkd.in/eDAJvjZg